+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Addictions Therapeutics Market 2021-2025- Product Image

Global Addictions Therapeutics Market 2021-2025

  • ID: 5237568
  • Report
  • January 2021
  • Region: Global
  • 120 pages
  • TechNavio

FEATURED COMPANIES

  • Alkermes Plc
  • GlaxoSmithKline Plc
  • Indivior Plc
  • Mallinckrodt Plc
  • Orexo AB
  • Otsuka Holdings Co. Ltd.
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Global Addictions Therapeutics Market 2021-2025

The publisher has been monitoring the addictions therapeutics market and it is poised to grow by $ 6.30 bn during 2021-2025 progressing at a CAGR of 6% during the forecast period. The report on addictions therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the high consumption of alcohol, tobacco, and opioid products and initiatives to increase awareness about and combat addiction. In addition, high consumption of alcohol, tobacco, and opioid products is anticipated to boost the growth of the market as well.

The addictions therapeutics market analysis includes type segment and geographical landscapes.

The addictions therapeutics market is segmented as below:

By Type
  • Alcohol addiction therapeutics
  • Tobacco addiction therapeutics
  • Drug addiction therapeutics
By Geographical Landscapes
  • North America
  • Europe
  • APAC
  • ROW
This study identifies the approval of new drugs and launch of digital therapeutics to treat addiction as one of the prime reasons driving the addictions therapeutics market growth during the next few years.

The report on addictions therapeutics market covers the following areas:
  • Addictions therapeutics market sizing
  • Addictions therapeutics market forecast
  • Addictions therapeutics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading addictions therapeutics market vendors that include Alkermes Plc, Emergent BioSolutions Inc., GlaxoSmithKline Plc, Indivior Plc, Mallinckrodt Plc, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Titan Pharmaceuticals Inc.. Also, the addictions therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alkermes Plc
  • GlaxoSmithKline Plc
  • Indivior Plc
  • Mallinckrodt Plc
  • Orexo AB
  • Otsuka Holdings Co. Ltd.
Executive Summary
  • Market Overview
Market Landscape
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
Market Sizing
  • Market definition
  • Market segment analysis
  • Market size 2020
  • Market outlook: Forecast for 2020-2025
Five Forces Analysis
  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
Market Segmentation by Type
  • Market segments
  • Comparison by Type
  • Alcohol addiction therapeutics - Market size and forecast 2020-2025
  • Tobacco addiction therapeutics - Market size and forecast 2020-2025
  • Drug addiction therapeutics - Market size and forecast 2020-2025
  • Market opportunity by Type
Customer landscape
  • Customer landscape
Geographic Landscape
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2020-2025
  • Europe - Market size and forecast 2020-2025
  • APAC - Market size and forecast 2020-2025
  • ROW - Market size and forecast 2020-2025
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends
Vendor Landscape
  • Competitive scenario
  • Vendor landscape
  • Landscape disruption
Vendor Analysis
  • Vendors covered
  • Market positioning of vendors
  • Alkermes Plc
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Indivior Plc
  • Mallinckrodt Plc
  • Orexo AB
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Titan Pharmaceuticals Inc.
Appendix
  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations
Exhibit
  • Key Finding 1
  • Key Finding 2
  • Key Finding 3
  • Key Finding 5
  • Key Finding 6
  • Key Finding 7
  • Key Finding 8
  • Parent market
  • Market characteristics
  • Offerings of vendors included in the market definition
  • Market segments
  • Global - Market size and forecast 2020 - 2025 ($ million)
  • Global market: Year-over-year growth 2020 - 2025 (%)
  • Five forces analysis 2020 & 2025
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition - Five forces 2020
  • Type - Market share 2020-2025 (%)
  • Comparison by Type
  • Alcohol addiction therapeutics - Market size and forecast 2020-2025 ($ million)
  • Alcohol addiction therapeutics - Year-over-year growth 2020-2025 (%)
  • Tobacco addiction therapeutics - Market size and forecast 2020-2025 ($ million)
  • Tobacco addiction therapeutics - Year-over-year growth 2020-2025 (%)
  • Drug addiction therapeutics - Market size and forecast 2020-2025 ($ million)
  • Drug addiction therapeutics - Year-over-year growth 2020-2025 (%)
  • Market opportunity by Type
  • Customer landscape
  • Market share by geography 2020-2025 (%)
  • Geographic comparison
  • North America - Market size and forecast 2020-2025 ($ million)
  • North America - Year-over-year growth 2020-2025 (%)
  • Europe - Market size and forecast 2020-2025 ($ million)
  • Europe - Year-over-year growth 2020-2025 (%)
  • APAC - Market size and forecast 2020-2025 ($ million)
  • APAC - Year-over-year growth 2020-2025 (%)
  • ROW - Market size and forecast 2020-2025 ($ million)
  • ROW - Year-over-year growth 2020-2025 (%)
  • Key leading countries
  • Market opportunity by geography ($ million)
  • Impact of drivers and challenges
  • Vendor landscape
  • Landscape disruption
  • Industry risks
  • Vendors covered
  • Market positioning of vendors
  • Alkermes Plc - Overview
  • Alkermes Plc - Product and service
  • Alkermes Plc - Key offerings
  • Alkermes Plc - Key customers
  • Alkermes Plc - Segment focus
  • Emergent BioSolutions Inc. - Overview
  • Emergent BioSolutions Inc. - Business segments
  • Emergent BioSolutions Inc. - Key offerings
  • Emergent BioSolutions Inc. - Key customers
  • Emergent BioSolutions Inc. - Segment focus
  • GlaxoSmithKline Plc - Overview
  • GlaxoSmithKline Plc - Business segments
  • GlaxoSmithKline Plc - Key offerings
  • GlaxoSmithKline Plc - Key customers
  • GlaxoSmithKline Plc - Segment focus
  • Indivior Plc - Overview
  • Indivior Plc - Product and service
  • Indivior Plc - Key offerings
  • Indivior Plc - Key customers
  • Indivior Plc - Segment focus
  • Mallinckrodt Plc - Overview
  • Mallinckrodt Plc - Business segments
  • Mallinckrodt Plc - Key offerings
  • Mallinckrodt Plc - Key customers
  • Mallinckrodt Plc - Segment focus
  • Orexo AB - Overview
  • Orexo AB - Product and service
  • Orexo AB - Key offerings
  • Orexo AB - Key customers
  • Orexo AB - Segment focus
  • Otsuka Holdings Co. Ltd. - Overview
  • Otsuka Holdings Co. Ltd. - Business segments
  • Otsuka Holdings Co. Ltd. - Key offerings
  • Otsuka Holdings Co. Ltd. - Key customers
  • Otsuka Holdings Co. Ltd. - Segment focus
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Business segments
  • Pfizer Inc. - Key offerings
  • Pfizer Inc. - Key customers
  • Pfizer Inc. - Segment focus
  • Teva Pharmaceutical Industries Ltd. - Overview
  • Teva Pharmaceutical Industries Ltd. - Business segments
  • Teva Pharmaceutical Industries Ltd. - Key offerings
  • Teva Pharmaceutical Industries Ltd. - Key customers
  • Teva Pharmaceutical Industries Ltd. - Segment focus
  • Titan Pharmaceuticals Inc. - Overview
  • Titan Pharmaceuticals Inc. - Product and service
  • Titan Pharmaceuticals Inc. - Key offerings
  • Titan Pharmaceuticals Inc. - Key customers
  • Titan Pharmaceuticals Inc. - Segment focus
  • Currency conversion rates for US$
  • Research Methodology
  • Validation techniques employed for market sizing
  • Information sources
  • List of abbreviations
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Alkermes Plc
  • GlaxoSmithKline Plc
  • Indivior Plc
  • Mallinckrodt Plc
  • Orexo AB
  • Otsuka Holdings Co. Ltd.
The publisher recognizes the following companies as the key players in the global addictions therapeutics market: Alkermes Plc, Emergent BioSolutions Inc., GlaxoSmithKline Plc, Indivior Plc, Mallinckrodt Plc, Orexo AB, Otsuka Holdings Co. Ltd., Pfizer Inc., Teva Pharmaceutical Industries Ltd., and Titan Pharmaceuticals Inc..

Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is approval of new drugs and launch of digital therapeutics to treat addiction.'

According to the report, one of the major drivers for this market is the high consumption of alcohol, tobacco, and opioid products.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Alkermes Plc
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline Plc
  • Indivior Plc
  • Mallinckrodt Plc
  • Orexo AB
  • Otsuka Holdings Co. Ltd.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Titan Pharmaceuticals Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll